LEGATO BIOLOGICS Accelerating Antibody & ADC Development about us Full CMC Service for Monoclonal Antibody, Bispecific Antibody, and ADC Development from IND to Phase 2 Trials Proprietary & Industry-leading uni-Qon™ Site-specific ADC Mono- & Dual-payload Conjugation Gene Synthesis to eCTD Filing Within 11 Months for Bispecific Antibody IND Submission with FDA From our CEO Jerry … Continue reading Home